reviewJournal of Controlled ReleaseMar 29, 2012Closed access

Doxil® — The first FDA-approved nano-drug: Lessons learned

YBYechezkel Barenholz
PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

4,530
total citations
FWCI
65.42
Percentile
100%
References
154
Citations per year

Authors

1

Topics & keywords

Topics
Keywords
  • Liposome
  • Drug
  • Pharmacology
  • Medicine
  • Doxorubicin
  • Drug development
  • Nanotechnology
  • Materials science
No related works found for this paper.